Vadivarhe Speciality

₹39.5 0 | 0%

WEBSITE BSE:0 NSE : 13 May, 00:00

Market Cap ₹50 Cr.

Stock P/E -7.9

P/B 7.9

Current Price ₹39.5

Book Value ₹ 5

Face Value 10

52W High ₹55

Dividend Yield 0%

52W Low ₹ 27.4

Edit Ratio

Vadivarhe Speciality Research see more...

Overview Inc. Year: 2009Industry: Chemicals

Vadivarhe Speciality Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Vadivarhe Speciality Quarterly Results

#(Fig in Cr.)	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Jun 2019	Dec 2019	Jun 2020	Dec 2020	Jun 2021	Dec 2021
Net Sales	6	8	6	12	11	5	7	4	4	6
Other Income	0	0	0	0	0	0	0	0	0	0
Total Income	6	8	6	12	11	5	7	4	4	6
Total Expenditure	5	6	6	11	10	8	7	5	5	8
Operating Profit	1	1	1	1	1	-3	0	-0	-1	-2
Interest	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Exceptional Income / Expenses	-0	0	0	0	0	0	0	0	0	0
Profit Before Tax	0	1	0	0	0	-4	-1	-1	-2	-3
Provision for Tax	0	0	-0	0	-0	1	0	0	0	0
Profit After Tax	0	1	0	0	0	-5	-1	-1	-2	-3
Adjustments	-0	-1	-0	0	0	0	0	0	-0	0
Profit After Adjustments	0	0	0	0	0	-5	-1	-1	-2	-3
Adjusted Earnings Per Share	0	0.5	0.1	0.2	0.1	-3.8	-0.6	-0.7	-1.5	-2.3

Vadivarhe Speciality Profit & Loss

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	13	14	19	26	35	26	32	30	26	21	44	21
Other Income	0	0	0	0	0	0	0	0	0	1	1	0
Total Income	13	14	19	26	35	26	33	30	27	22	45	21
Total Expenditure	15	11	12	19	25	22	30	39	27	28	41	25
Operating Profit	-2	3	8	8	11	4	3	-9	-0	-6	4	-3
Interest	1	1	1	1	1	1	1	1	1	2	2	0
Depreciation	2	2	1	1	1	1	2	2	2	2	2	0
Exceptional Income / Expenses	0	0	0	0	1	0	0	0	1	0	0	0
Profit Before Tax	-5	0	6	5	9	2	0	-12	-3	-10	1	-7
Provision for Tax	-2	0	2	2	3	0	-0	-2	0	0	0	0
Profit After Tax	-3	0	4	3	6	2	0	-10	-3	-10	1	-7
Adjustments	0	0	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	-3	0	4	3	6	2	0	-10	-3	-10	1	-7
Adjusted Earnings Per Share	0	0	0	0	0	1.4	0	-7.7	-2.2	-7.5	0.9	-5.1

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	110%	14%	11%	13%
Operating Profit CAGR	0%	0%	0%	0%
PAT CAGR	0%	0%	-13%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	35%	34%	6%	NA%
ROE Average	20%	-31%	-27%	-7%
ROCE Average	9%	-6%	-8%	3%

Vadivarhe Speciality Balance Sheet

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	10	11	15	18	23	27	27	18	15	5	6
Minority's Interest	0	0	0	0	0	0	0	0	0	0	0
Borrowings	17	12	8	5	4	4	13	10	15	16	16
Other Non-Current Liabilities	-3	-2	-1	1	3	3	3	1	1	1	0
Total Current Liabilities	4	10	6	9	15	9	15	23	17	20	23
Total Liabilities	29	30	28	34	46	44	58	51	47	42	46
Fixed Assets	18	16	15	15	17	20	26	25	26	24	23
Other Non-Current Assets	5	5	6	7	7	8	8	5	2	3	3
Total Current Assets	6	9	8	13	22	16	23	21	19	14	20
Total Assets	29	30	28	34	46	44	58	51	47	42	46

Vadivarhe Speciality Cash Flow

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	0	0	0	1	0	0	1	1	1	1	1
Cash Flow from Operating Activities	-3	7	5	4	2	7	-1	4	-0	1	-0
Cash Flow from Investing Activities	-1	-0	-0	-1	-4	-5	-8	-2	0	-1	-1
Cash Flow from Financing Activities	4	-6	-4	-4	2	-1	9	-2	1	-1	1
Net Cash Inflow / Outflow	0	0	1	-1	-0	1	-0	0	0	-0	0
Closing Cash & Cash Equivalent	0	0	1	0	0	1	1	1	1	1	1

Vadivarhe Speciality Ratios

#	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	0	0	0	0	0	1.38	0.05	-7.7	-2.16	-7.52	0.9
CEPS(Rs)	-1.41	1.43	4.19	3.65	5.91	2.38	1.32	-6.33	-0.75	-6.12	2.3
DPS(Rs)	0	0	0	0	0	0	0	0	0	0	0
Book NAV/Share(Rs)	0	0	0	0	0	21.46	21.5	13.81	11.65	4.13	5.03
Core EBITDA Margin(%)	-16.6	18.61	38.36	26.47	28.33	14.56	7.18	-30.66	-2.33	-32.29	7.02
EBIT Margin(%)	-28.67	7.96	33.33	23.28	28.08	11.37	3.6	-35.21	-4.82	-36.9	6.3
Pre Tax Margin(%)	-36.73	0.89	28.79	18.95	25.76	8.39	0.16	-39.76	-9.79	-44.79	2.63
PAT Margin (%)	-24.93	0.5	20.29	12.1	16.37	6.82	0.19	-32.64	-10.43	-44.79	2.63
Cash Profit Margin (%)	-12.5	11.93	25.86	15.8	19.47	11.74	5.22	-26.84	-3.6	-36.45	6.72
ROA(%)	-11.76	0.25	13.61	10.81	15.07	3.93	0.12	-18.04	-5.6	-21.62	2.6
ROE(%)	-32.31	0.69	31.7	20.84	29.06	6.94	0.23	-43.6	-16.97	-95.27	19.6
ROCE(%)	-13.74	4.22	24.36	23.24	31.84	8.03	2.72	-24.74	-3.37	-23.27	8.73
Receivable days	69.26	97.29	82.24	79.53	118.25	168.78	120.2	126.36	119.14	94.74	32.57
Inventory Days	52.13	44.9	26.56	23.92	21.9	35.76	54.62	81.32	70.16	86.49	64.34
Payable days	146.65	168.9	108.05	60.71	92.79	162.94	128.06	150.19	212.87	190.97	135.23
PER(x)	0	0	0	0	0	61.27	762.89	0	0	0	30.7
Price/Book(x)	0	0	0	0	0	3.95	1.72	0.47	1.08	6.05	5.48
Dividend Yield(%)	0	0	0	0	0	0	0	0	0	0	0
EV/Net Sales(x)	1.72	1.46	0.86	0.57	0.71	4.58	2.09	0.9	1.46	2.59	1.4
EV/Core EBITDA(x)	-10.25	7.21	2.14	1.99	2.3	28.19	24.25	-3.03	-173.89	-8.71	14.71
Net Sales Growth(%)	0	5.41	37.15	38.13	33.28	-27.03	26.6	-6.85	-12.18	-18.97	103.64
EBIT Growth(%)	0	129.53	467.42	-0.48	58.57	-71.47	-60.42	-1011.56	87.99	-520.87	134.79
PAT Growth(%)	0	102.15	5347.26	-15.04	77.91	-70.62	-96.49	0	71.94	-248.05	111.94
EPS Growth(%)	0	0	0	0	0	0	-96.49	0	71.94	-248.05	111.94
Debt/Equity(x)	1.7	1.48	0.89	0.59	0.54	0.35	0.76	1.11	1.57	4.62	4.19
Current Ratio(x)	1.51	0.87	1.28	1.37	1.4	1.72	1.58	0.92	1.11	0.72	0.86
Quick Ratio(x)	1.04	0.71	1.08	1.11	1.27	1.39	1.13	0.62	0.91	0.38	0.5
Interest Cover(x)	-3.56	1.13	7.34	5.38	12.1	3.81	1.05	-7.74	-0.97	-4.68	1.71
Total Debt/Mcap(x)	0	0	0	0	0	0.09	0.44	2.39	1.46	0.76	0.76

Vadivarhe Speciality Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	74.62	74.64	74.64	74.64	74.64	74.64	74.64	74.64	74.64	74.64
FII	0	0	0	0	0	0	0	0	0	0
DII	0	0	0	0	0	0	0	0	0	0
Public	25.38	25.36	25.36	25.36	25.36	25.36	25.36	25.36	25.36	25.36
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	0.95	0.95	0.95	0.95	0.95	0.95	0.95	0.95	0.95	0.95
FII	0	0	0	0	0	0	0	0	0	0
DII	0	0	0	0	0	0	0	0	0	0
Public	0.32	0.32	0.32	0.32	0.32	0.32	0.32	0.32	0.32	0.32
Others	0	0	0	0	0	0	0	0	0	0
Total	1.28	1.28	1.28	1.28	1.28	1.28	1.28	1.28	1.28	1.28

Pros

Debtor days have improved from 190.97 to 135.23days.

Cons

Company has a low return on equity of -31% over the last 3 years.
Stock is trading at 7.9 times its book value.
The company has delivered a poor profit growth of -12% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.